Blue Chip Capital Group Inc. has taken a significant step in increasing its market presence by securing a quotation for its common stock on the OTC Markets. This development, reported in a recent SEC filing, highlights the company’s efforts to enhance its visibility and attract potential investors.

On November 9, 2026, the company’s common stock was initially approved for quotation on the OTCID, the Basic Market of OTC Markets. As of November 11, 2026, the stock was quoted at $0.90 per share. This approval is crucial for Blue Chip as it seeks to meet the minimal current information standard required for trading on the OTC Markets.

Blue Chip Capital Group Inc., identified by the ticker symbol BCCG, operates within the finance services sector, as classified under SIC 6199. The company is based in Beverly Hills, California, and is categorized as a smaller reporting company and an emerging growth company.

The recent SEC filing, accession number 0001493152-26-051593, outlines the company’s journey toward gaining a foothold in the OTC market. It notes that the Financial Industry Regulatory Authority (FINRA) processed a Form 211 related to the initiation of priced quotations for the company’s common stock. The submitting broker-dealer, Glendale Securities, Inc., demonstrated compliance with FINRA Rule 6432, allowing them to initiate a priced quotation.

As of November 10, 2026, Blue Chip had 25,548,246 unrestricted shares of common stock, with 4,825,000 shares held at DTC (Depository Trust Company). The company expects that by December 10, 2026, the remaining shares will also be deposited with DTC, making them available for trading. This step is essential for the company as it aims to meet the requirements for trading on the OTCQB Venture Market.

To qualify for the OTCQB, companies must be current in their reporting obligations with the SEC and have filed audited financial statements. Blue Chip believes it meets these requirements, having filed its annual reports on Form 10-K since it became obligated to report under the Exchange Act.

However, the company faces challenges in meeting the minimum bid price requirement of $0.05 per share for 30 consecutive calendar days prior to its admission to the OTCQB. Currently, Blue Chip has not yet met this requirement, as its common stock only obtained DTC eligibility on November 6, 2026.

Blue Chip’s efforts to secure a position on the OTCQB are ongoing, and the company intends to request approval from OTC Markets Group for conditional admission based on its ability to demonstrate compliance with the minimum bid price requirement. However, the filing does not guarantee that the company will satisfy the criteria for trading on the OTCQB or that its application will be approved.

As Blue Chip Capital Group Inc. continues to navigate the complexities of the OTC Markets, its progress will be closely watched by investors and competitors alike. The finance services industry remains competitive, and Blue Chip’s ability to establish itself in this space could influence its future growth and market positioning.